AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12049862
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (control)
Trial: 1657680
Drug: Mucolytic-antifoam solution
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mucolytic-antifoam solution (simethicone, acetylcysteine, sodium bicarbonate)
Trial: 31697010
Drug: Topical tioconazole
RxNorm normalized name: tioconazole Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tioconazole 28% for 16 weeks
Trial: 26511807
Drug: Pemetrexed-Cisplatin followed
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pemetrexed-Cisplatin followed by Gefitinib maintenance therapy (PC/G)
Trial: 769169
Drug: L-dopa
RxNorm normalized name: L-dopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: L-dopa
Trial: 11252650
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel antagonists (CCAs)
Trial: 8489062
Drug: Intranasal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal midazolam (0.2 mg/kg)
Trial: 15760536
Drug: Cranial hypothermia
RxNorm normalized name: geranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranial hypothermia treatment started in 7-10 hours (Group B)
Trial: 9538976
Drug: Human regular
RxNorm normalized name: Human regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human regular insulin (HR)
Trial: 30724658
Drug: MR with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MR with monovalent mumps vaccine (Hoshino strain)
Trial: 29364495
Drug: L. plantarum
RxNorm normalized name: Lactobacillus acidophilus/L. plantarum/Bifido no.7 15 billion cell ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. plantarum P17630 (5x10^9 CFU/capsule)
Trial: 18833117
Drug: Atomoxetine (strattera)
RxNorm normalized name: atomoxetine Oral Capsule [Strattera]
DrugBank: Atomoxetine (DB00289)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atomoxetine (strattera) in daily dosage 0.8‐1.2 mg/kg as a monotherapy for 6 weeks
Trial: 1108645
Drug: Traditional drug
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional drug administration during hospitalization and self-medication as an outpatient
Trial: 25909320
Drug: Mobile health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobile health intervention with additional medication reminders and adherence assessment via text message
Trial: 23447696
Drug: Dihydroartemisinin-piperaquine (DP)
RxNorm normalized name: .alpha.-dihydroartemisinin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroartemisinin-piperaquine (DP) treatment without TMP-SMX prophylaxis
Trial: 3975255
Drug: Buffered aspirin
RxNorm normalized name: Buffered Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buffered aspirin tablets
Trial: 29373334
Drug: Manual vasopressor
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual vasopressor bolus administration
Trial: 12645994
Drug: RWJ-270201 (BCX-1812)
RxNorm normalized name: RWJ-800088
DrugBank: RWJ-800088 (DB18693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RWJ-270201 (BCX-1812) 200 mg/bid
Trial: 12645994
Drug: RWJ-270201 (BCX-1812)
RxNorm normalized name: RWJ-800088
DrugBank: RWJ-800088 (DB18693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RWJ-270201 (BCX-1812) 400 mg/qd
Trial: 12645994
Drug: RWJ-270201 (BCX-1812)
RxNorm normalized name: RWJ-800088
DrugBank: RWJ-800088 (DB18693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RWJ-270201 (BCX-1812) 800 mg on Day 1 followed by 400 mg on Days 2-5
Trial: 10068412
Drug: Bedtime insulin
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime insulin plus glyburide
Trial: 9756471
Drug: Interferon-alpha-2b (IFN)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha-2b (IFN) therapy
Trial: 31876197
Drug: Dydrogesterone supplementation
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dydrogesterone supplementation (30 mg/d)
Trial: 23812136
Drug: Preoperative bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative bowel preparation (group A)
Trial: 15625158
Drug: Extended-release venlafaxine
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release venlafaxine 75 mg daily for 12 weeks
Trial: 25111121
Drug: Sucrose (SUC)
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose (SUC) or high fructose corn syrup (HFCS) in low-fat milk at 8%, 18% or 30% of calories
Trial: 9515666
Drug: Imipenem 3
RxNorm normalized name: Imipenem
DrugBank: Imipenem (DB01598)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Imipenem 3 x 1.0 g per day
Trial: 9515666
Drug: Imipenem 3
RxNorm normalized name: Imipenem
DrugBank: Imipenem (DB01598)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Imipenem 3 x 0.5 g per day
Trial: 17714055
Drug: Fentanyl buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl buccal tablet (FBT) doses of 270-1300 microg in Study 2
Trial: 2147787
Drug: All eight
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All eight tested saliva stimulants and substitutes
Trial: 8733437
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 7.5 mg/week
Trial: 30548121
Drug: Standard formula
RxNorm normalized name: Standard formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard formula 67 kcal/100 mL for 7 days
Trial: 3341246
Drug: Multivitamin and
RxNorm normalized name: Multivitamin and Minerals Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin and mineral supplement for 3 months
Trial: 31432392
Drug: Adverse events
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse events for intravenous posaconazole 300 mg
Trial: 23452682
Drug: Cumulative stimulant
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative stimulant treatment over time
Trial: 18090697
Drug: Continuation therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation therapy with ECT
Trial: 18090697
Drug: Continuation therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation therapy with medications
Trial: 16846931
Drug: Immunostimulating vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunostimulating vaccine (group B) for 3 months
Trial: 7598769
Drug: Simultaneous administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simultaneous administration of all vaccines
Trial: 23377513
Drug: Clindamycin gel
RxNorm normalized name: clindamycin Topical Gel
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clindamycin gel (1% clindamycin phosphate)
Trial: 20650919
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (1.5 mg kg(‐1) bolus then 2 mg kg(‐1) h(‐1) infusion)
Trial: 8153921
Drug: Beta 2
RxNorm normalized name: Beta 2 globulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta 2 agonist plus corticosteroid (BA + CS) treatment
Trial: 1301232
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg propranolol
Trial: 9104623
Drug: Dexamethasone pre-treatment
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone pre-treatment
Trial: 15812205
Drug: Endorectal enema
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endorectal enema of 1% lidocaine gel (group B)
Trial: 12953850
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (perindopril 4 mg daily, with optional indapamide)
Trial: 8017465
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg with the evening meal
Trial: 8017465
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg at bedtime
Trial: 25636814
Drug: Both WBVT
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both WBVT interventions (WBVT and WBVT + L-citrulline)
Trial: 23065090
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 mg daily for 4 weeks
Trial: 22035999
Drug: Psychotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy treatment
Trial: 9015888
Drug: Western treatment
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western treatment
Trial: 2945704
Drug: 1 percent
RxNorm normalized name: CAPSAICIN 0.1 g in 100 g TOPICAL CREAM [Capsaicin 0.1 Percent]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 percent clindamycin phosphate lotion
Trial: 24506950
Drug: Telephone-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-delivered cognitive behavioral therapy (CBT-T)
Trial: 6720281
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment with antibiotics and corticosteroid (from the third post-operative day)
Trial: 26742068
Drug: Normal protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein (12 g) + high fiber (8 g)
Trial: 19256406
Drug: Monthly phone
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly phone contact (PHCG)
Trial: 8156285
Drug: Hydroxychloroquine tablet
RxNorm normalized name: hydroxychloroquine Oral Tablet
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine tablet (155 mg)
Trial: 17380263
Drug: Body mass
RxNorm normalized name: Total Body Massager Item
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body mass index (BMI) and injection site
Trial: 8072258
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CsA) at a dosage of 5.54 ± 0.81 mg/kg/day for 12 to 60 months
Trial: 23676253
Drug: 40 IU
RxNorm normalized name: Oxytocin 40 IU/1 ML Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 IU intranasal oxytocin
Trial: 19547811
Drug: bromazepam 6
RxNorm normalized name: bromazepam 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromazepam 6 mg
Trial: 10207807
Drug: Interferon therapy
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon therapy
Trial: 20034440
Drug: Conventional needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional needle injection acupuncture
Trial: 27776149
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg caffeine
Trial: 14736293
Drug: Hill-climbing heuristic
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hill-climbing heuristic applied to the 6-coin problem with a concrete and visualizable solution
Trial: 24535134
Drug: IFNβ-1a IM
RxNorm normalized name: PEG IFN-beta-1a
DrugBank: Peginterferon beta-1a (DB09122)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IFNβ-1a IM 30 μg once-weekly
Trial: 29081664
Drug: everolimus 10
RxNorm normalized name: everolimus 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: everolimus 10 mg/day
Trial: 16569807
Drug: Atenolol-based hypertension
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol-based hypertension treatment
Trial: 21314440
Drug: Oral combination
RxNorm normalized name: clozapine ORAL COMBINATION PACKAGE (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral combination of desmin (300 mg/day) and troxerutin (300 mg/day) with Centella asiatica (30 mg/day) and Melilotus (160 mg/day) for 14 months
Trial: 2860283
Drug: Temazepam 20
RxNorm normalized name: temazepam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam 20 mg in soft gelatine capsule
Trial: 11408210
Drug: Isoniazid (INH)
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid (INH) 5 mg/kg daily
Trial: 11408210
Drug: Isoniazid (INH)
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid (INH) 5 mg/kg daily and 25 mg of rifalazil once weekly
Trial: 9495409
Drug: 0.025 mg
RxNorm normalized name: lisuride 0.025 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025 mg intrathecal morphine plus 75 mg i.m. diclofenac every 8 h
Trial: 30981162
Drug: Guided internet-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided internet-based cognitive behavioural therapy (ICBT)
Trial: 12657911
Drug: Racemic reboxetine
RxNorm normalized name: REBOXETINE
DrugBank: Reboxetine (DB00234)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic reboxetine (therapeutic drug monitoring)
Trial: 11084270
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine 0.5% administered 30 minutes preoperatively
Trial: 1869364
Drug: Albendazole 1200
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole 1200 mg x 3 days
Trial: 30622317
Drug: Irbesartan 150
RxNorm normalized name: irbesartan 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 150 mg
Trial: 17356554
Drug: Probiotic capsules
RxNorm normalized name: Quad-Probiotic Capsules
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsules (3 capsules daily containing 10^9 CFU Lactobacillus acidophilus and Bifidobacterium longum, 10-15 mg fructo-oligosaccharide)
Trial: 9732168
Drug: Topical calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcipotriol (50 microgram/g) applied twice daily
Trial: 7995005
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg ordinary-release theophylline
Trial: 25001663
Drug: Nutraceutical combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutraceutical combination (red yeast rice, Silybum marianum, octasonol)
Trial: 14647955
Drug: Active priming
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active priming injection of cocaine (0, 15 or 30 mg/70 kg)
Trial: 10552188
Drug: tedisamil 100
RxNorm normalized name: tedisamil
DrugBank: Tedisamil (DB06200)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tedisamil 100 mg b.i.d.
Trial: 1696662
Drug: atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol 50 mg b.i.d.
Trial: 29070709
Drug: HP-BEEF diet
RxNorm normalized name: Beef
DrugBank: Beef (DB10509)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HP-BEEF diet (124 g protein/d; 60% from beef, 40% from plant sources)
Trial: 17112693
Drug: Ibuprofen 1200
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 1200 mg/day
Trial: 28744857
Drug: Pre-operative intravenous
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative intravenous methylprednisolone 125 mg
Trial: 8600742
Drug: Repair with
RxNorm normalized name: AVOBENZONE 30 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL CREAM [Exuviance Age Reverse Day Repair with Sunscreen Broad Spectrum SPF 30]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repair with synthetic augmentation
Trial: 25925875
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba (80-120 mg/day)
Trial: 17898337
Drug: Lowering the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lowering the dosages of antiparkinsonian medications
Trial: 10396191
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of 5‐isosorbide mononitrate (ISMO)
Trial: 346315
Drug: Halcinonide solution
RxNorm normalized name: Halcinonide
DrugBank: Halcinonide (DB06786)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Halcinonide solution (0.1%)
Trial: 15536460
Drug: Oral ALF
RxNorm normalized name: ALF component monophosphoryl lipid A
DrugBank: Monophosphoryl lipid A (DB19290)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ALF after rifampin
Trial: 15536460
Drug: Oral ALF
RxNorm normalized name: ALF component monophosphoryl lipid A
DrugBank: Monophosphoryl lipid A (DB19290)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ALF after troleandomycin (TAO)
Trial: 15536460
Drug: Oral ALF
RxNorm normalized name: ALF component monophosphoryl lipid A
DrugBank: Monophosphoryl lipid A (DB19290)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ALF after grapefruit juice
Trial: 9493975
Drug: Control arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control arm (no adjuvant therapy)
Trial: 18256460
Drug: Formulation containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation containing ziyuglycoside I
Trial: 22642182
Drug: 15-session crafts
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 15-session crafts program or no treatment
Trial: 2440626
Drug: Cisplatinum treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatinum treatment
Trial: 2440626
Drug: Cisplatinum treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatinum treatment in advanced previously untreated disease
Trial: 9230825
Drug: Physostigmine salicylate
RxNorm normalized name: PHYSOSTIGMINE SALICYLATE
DrugBank: Physostigmine (DB00981)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine salicylate (8 mg/mL)
Trial: 26703279
Drug: Sustained-release dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sustained-release dexamethasone
Trial: 4014796
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg ergometrine by slow intravenous injection
Trial: 30086408
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (OXT)
Trial: 8778603
Drug: sodium benzoate,
RxNorm normalized name: Sodium Benzoate, Powder, NF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sodium benzoate, alone or in combination with sodium phenylacetate or sodium phenylbutyrate, or sodium phenylbutyrate alone
Trial: 8778603
Drug: drugs that
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: drugs that activate new pathways of waste‐nitrogen excretion
Trial: 2144797
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic factor (ANF) infusion (50 ng/kg/min)
Trial: 20705215
Drug: Serotonin noradrenaline
RxNorm normalized name: serotonin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin noradrenaline reuptake inhibitors
Trial: 10565463
Drug: CSF glycine
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CSF glycine levels in newborns with moderate HIE (19.1 micromol/l)
Trial: 10565463
Drug: CSF glycine
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CSF glycine levels in control group (12.08 micromol/l)
Trial: 2899773
Drug: Alternative therapies
RxNorm normalized name: HERBS/ALTERNATIVE THERAPIES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative therapies usually prescribed in France
Trial: 24814037
Drug: 3g red
RxNorm normalized name: Red gum
DrugBank: Eucalyptus gum (DB15537)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3g red ginseng daily for 12 weeks